HKI-272
Showing 1 - 25 of 68
Breast Cancer Trial in United States (HKI-272, Surgical Resection, Capecitabine)
Active, not recruiting
- Breast Cancer
- HKI-272
- +3 more
-
San Francisco, California
- +17 more
Jan 30, 2023
Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,
Recruiting
- Advanced Malignant Solid Neoplasm
- +9 more
- Everolimus
- +3 more
-
Houston, TexasM D Anderson Cancer Center
Oct 25, 2022
Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial in New Haven (procedure, drug, biological)
Recruiting
- Metastatic Malignant Solid Neoplasm
- Unresectable Malignant Solid Neoplasm
- Biopsy
- +2 more
-
Boston, Massachusetts
- +2 more
Jan 25, 2023
Malignant Female Reproductive System Tumor, Malignant Solid Tumor, Recurrent Malignant Female Reproductive System Tumor Trial
Not yet recruiting
- Malignant Female Reproductive System Neoplasm
- +3 more
- Biopsy
- +7 more
- (no location specified)
Nov 9, 2023
Advanced Malignant Solid Tumors Trial in Shizuoka, Tokyo (Neratinib, Capecitabine)
Completed
- Advanced Malignant Solid Tumors
-
Shizuoka, Japan
- +1 more
Dec 18, 2018
Advanced Malignant Solid Tumors Trial in Shizuoka, Tokyo (Neratinib, Paclitaxel)
Completed
- Advanced Malignant Solid Tumors
-
Shizuoka, Japan
- +1 more
Apr 24, 2018
HER2-positive Breast Cancer, Breast Adenocarcinoma, Stage II Breast Cancer AJCC v6 and v7 Trial in San Francisco (Neratinib,
Completed
- HER2-positive Breast Cancer
- +8 more
- Neratinib
- +3 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Jan 6, 2023
Advanced Breast Cancer Trial in Worldwide (HKI-272, trastuzumab)
Advanced Malignant Solid Tumors Trial in Shizuoka, Tokyo (Neratinib, Vinorelbine)
Completed
- Advanced Malignant Solid Tumors
-
Shizuoka, Japan
- +1 more
Apr 24, 2018
Tumors, Malignant Carcinoma Trial in Boston, Villejuif (Neratinib, Temsirolimus)
Completed
- Neoplasms
- Malignant Carcinoma
-
Boston, Massachusetts
- +4 more
Aug 17, 2018
Human Immunodeficiency Virus Trial in Sweetwaters (A couples-focused intervention for HIV prevention and care in South Africa)
Recruiting
- Human Immunodeficiency Virus
- A couples-focused intervention for HIV prevention and care in South Africa
-
Sweetwaters, KwaZulu Natal, South AfricaHuman Sciences Research Council
May 3, 2022
Breast Cancer, Advanced Malignant Solid Tumors Trial in Worldwide (neratinib, vinorelbine)
Completed
- Breast Cancer
- Advanced Malignant Solid Tumors
-
Fayetteville, Arkansas
- +34 more
Jul 11, 2018
Advanced Breast Cancer, Advanced Malignant Solid Tumors, Breast Tumors Trial in Worldwide (HKI-272, Paclitaxel)
Completed
- Advanced Breast Cancer
- +2 more
- HKI-272
- Paclitaxel
-
La Jolla, California
- +31 more
Jun 27, 2018
NSCLC, Lung Tumors Trial in Worldwide (HKI-272)
Completed
- Carcinoma, Non-Small-Cell Lung
- Lung Neoplasms
- HKI-272
-
Los Angeles, California
- +18 more
Apr 6, 2018
NSCLC Trial in Guangzhou (inetetamab, Pytotinib)
Recruiting
- Non-small Cell Lung Cancer
-
Guangzhou, Guangdong, ChinaSun Yat-Sen University Cancer Center
Aug 16, 2021
Obesity, Diet, Healthy Trial in Miami (Snackability app, Control group)
Completed
- Obesity
- Diet, Healthy
- Snackability app
- Control group
-
Miami, FloridaFlorida International University
Mar 21, 2022
Food Selection Trial in Minneapolis (Intervention Food Pantries, Control Food Pantries)
Terminated
- Food Selection
- Intervention Food Pantries
- Control Food Pantries
-
Minneapolis, MinnesotaUniversity of Minnesota
Oct 1, 2021
Respiratory Syncytial Virus (RSV) Follow-Up Study (MK-0476-374)
Completed
- Respiratory Syncytial Virus Bronchiolitis
- (no location specified)
Jan 31, 2022
Hemodynamic Rebound Trial in Jhelum (Tracheal Intubation)
Completed
- Hemodynamic Rebound
- Tracheal Intubation
-
Jhelum, Punjab, PakistanCMH
Nov 23, 2021